Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

News Conference News TVT 2023

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Michael O'Riordan

June 12, 2023

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

Preventing Permanent Pacemakers: Procedural Optimization to Minimize Conduction Disturbances

Presentation TVT 2022

Preventing Permanent Pacemakers: Procedural Optimization to Minimize Conduction Disturbances

Presenter: Amit Vora

June 10, 2022

Decreasing Permanent Pacemaker Implantation Rates in the STS/ACC TVT Registry with a Supra-annular Self-expanding Transcatheter Heart Valve

Presentation TVT 2022

Decreasing Permanent Pacemaker Implantation Rates in the STS/ACC TVT Registry with a Supra-annular Self-expanding Transcatheter Heart Valve

Presenter: James Harvey

June 09, 2022

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

News Conference News TVT 2021

Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’

July 23, 2021

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

Predictors of Late (≥ 30 Days) Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement

Presentation TVT 2019

Predictors of Late (≥ 30 Days) Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement

Presenter: Alexis Okoh

June 14, 2019

Tricuspid MitralClip in TR With a Permanent Pacemaker

Presentation TVT 2019

Tricuspid MitralClip in TR With a Permanent Pacemaker

Presenter: Fabien Praz

June 14, 2019

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

June 16, 2017

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.